Literature DB >> 32874883

Association of chronic periodontitis and type 2 diabetes mellitus with salivary Del-1 and IL-17 levels.

Somil Saxena1, Ranganath Venugopal2, Rachana Chandrayan Rao2, Monal B Yuwanati1, Harshita Awasthi2, Megha Jain1.   

Abstract

PURPOSE: Chronic periodontitis (CP) and Type 2 diabetes mellitus (T2DM) are chronic diseases affecting the humans and have interrelationship in their pathogenesis. Monitoring the progress with biomarker in these disease is important from treatment outcome point of view. We investigated the association of salivary developmental endothelial locus-1 (Del-1) and interleukin-17 (IL-17) levels in CP and T2DM.
METHODS: Saliva was collected from 17 healthy and 68 patients (divided into 4 groups based on presence or absence of CP and T2DM). Periodontal parameters were recorded at the time of visit. Del-1 and IL-17 levels in unstimulated salivary samples were determined using enzyme-linked immunosorbent assay.
RESULTS: Study found the lower levels of salivary Del-1 and higher levels of IL-17 in CP (2.23 ± 2.10 ng/mL, 56.54 ± 19.79 ng/mL), CCDM ((1.97 ± 1.36 ng/mL, 74.74 ± 17.79 ng/mL) and CUDM (1.02 ± 0.52 ng/mL, 63.84 ± 24.72 ng/mL) as compared to healthy individuals (6.54 ± 2.07; 24.47 ± 8.23 ng/mL) (p < 0.001). Del-1 and IL-17 levels were correlating with inflammatory state in CP and presence of T2DM aggravate the severity of disease in CP. An inverse correlation between salivary Del-1 & IL-17 levels was also seen. Furthermore, we also observed that the combination of T2DM and CP (CCDM and CUDM) increases the salivary IL-17 levels and decreases Del-1 levels.
CONCLUSIONS: There is an upregulation of salivary IL-17 and downregulation of salivary Del-1 with increase in severity of periodontal disease as well as T2DM. Furthermore, the presence of T2DM in chronic periodontitis patients can aggravate the inflammation related periodontal destruction.
© 2020 Craniofacial Research Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic periodontitis; Developmental endothelial locusl-1 protein; Interleukin-17; Salivary biomarker; Type 2 Diabetes mellitus

Year:  2020        PMID: 32874883      PMCID: PMC7452335          DOI: 10.1016/j.jobcr.2020.08.013

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  31 in total

Review 1.  Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases.

Authors:  T E Van Dyke; C N Serhan
Journal:  J Dent Res       Date:  2003-02       Impact factor: 6.116

2.  Signs of the presence of Th17 cells in chronic periodontal disease.

Authors:  M Adibrad; P Deyhimi; M Ganjalikhani Hakemi; P Behfarnia; M Shahabuei; L Rafiee
Journal:  J Periodontal Res       Date:  2012-02-06       Impact factor: 4.419

3.  Cytokine levels in sites of chronic periodontitis of poorly controlled and well-controlled type 2 diabetic subjects.

Authors:  Vanessa Renata Santos; Fernanda Vieira Ribeiro; Jadson Almeida Lima; Marcelo Henrique Napimoga; Marta Ferreira Bastos; Poliana Mendes Duarte
Journal:  J Clin Periodontol       Date:  2010-09-28       Impact factor: 8.728

4.  Developmental endothelial locus-1 (Del-1) antagonizes Interleukin-17-mediated allergic asthma.

Authors:  Shu Yan; Li Chen; Qi Zhao; Ya-Nan Liu; Rui Hou; Jing Yu; Hong Zhang
Journal:  Immunol Cell Biol       Date:  2018-03-09       Impact factor: 5.126

5.  The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus.

Authors:  Mine Kiran; Nejat Arpak; Elif Unsal; Murat Faik Erdoğan
Journal:  J Clin Periodontol       Date:  2005-03       Impact factor: 8.728

6.  IL-17 in sera from patients with aggressive periodontitis.

Authors:  H A Schenkein; T E Koertge; C N Brooks; R Sabatini; D E Purkall; J G Tew
Journal:  J Dent Res       Date:  2010-04-16       Impact factor: 6.116

7.  Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus.

Authors:  G W Taylor; B A Burt; M P Becker; R J Genco; M Shlossman; W C Knowler; D J Pettitt
Journal:  J Periodontol       Date:  1996-10       Impact factor: 6.993

8.  Salivary Concentrations of Interleukin (IL)-1β, IL-17A, and IL-23 Vary in Relation to Periodontal Status.

Authors:  Joonas Liukkonen; Ulvi K Gürsoy; Pirkko J Pussinen; Anna L Suominen; Eija Könönen
Journal:  J Periodontol       Date:  2016-08-19       Impact factor: 6.993

9.  Association study between salivary levels of interferon (IFN)-gamma, interleukin (IL)-17, IL-21, and IL-22 with chronic periodontitis.

Authors:  D M Isaza-Guzmán; N Cardona-Vélez; D E Gaviria-Correa; M C Martínez-Pabón; M C Castaño-Granada; S I Tobón-Arroyave
Journal:  Arch Oral Biol       Date:  2014-09-28       Impact factor: 2.633

10.  Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway.

Authors:  Tomoki Maekawa; Kavita Hosur; Toshiharu Abe; Alpdogan Kantarci; Athanasios Ziogas; Baomei Wang; Thomas E Van Dyke; Triantafyllos Chavakis; George Hajishengallis
Journal:  Nat Commun       Date:  2015-09-16       Impact factor: 14.919

View more
  2 in total

1.  DEL-1: a potential therapeutic target in inflammatory and autoimmune disease?

Authors:  George Hajishengallis; Triantafyllos Chavakis
Journal:  Expert Rev Clin Immunol       Date:  2021-04-19       Impact factor: 5.124

Review 2.  Role of Interleukin-17A in the Pathomechanisms of Periodontitis and Related Systemic Chronic Inflammatory Diseases.

Authors:  Yi Feng; Zheng Chen; Shao-Qin Tu; Jia-Ming Wei; Yu-Luan Hou; Zhi-Li Kuang; Xiao-Ning Kang; Hong Ai
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.